Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xiangyu Medical CoSHSE:688626 -0.80%91 OCF Margin % is 11.15% as of Jun. 2026, which is 64% below its 10-year median of 30.60. GuruFocus rates SHSE:688626 with a GF Score™ of 91/100 and a GF Value™ of ¥46.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Xiangyu Medical Co ranks better than 85.59% on this metric.
The historical rank and industry rank for Xiangyu Medical Co's OCF Margin % or its related term are showing as below:
SHSE:688626'
s OCF Margin % Range Over the Past 10 Years
Min: 20.51 Med: 30.6 Max: 43.67
Current: 23.09
During the past 9 years, the highest OCF Margin % of Xiangyu Medical Co was 43.67%. The lowest was 20.51%. And the median was 30.60%.
SHSE:688626's OCF Margin % is ranked better than 85.59% of 812
companies
in the Medical Devices & Instruments industry
Industry Median: 6.645
vs SHSE:688626: 23.09
The historical data trend for Xiangyu Medical Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688626 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Xiangyu Medical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xiangyu Medical Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Xiangyu Medical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Xiangyu Medical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xiangyu Medical Co (SHSE:688626) has a OCF Margin % of 11.15% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Xiangyu Medical Co and its competitors. This is 64% below median its historical median of 30.60. Over the past decade, Xiangyu Medical Co's OCF Margin % has ranged from 20.51 to 43.67. According to the industry distribution chart, Xiangyu Medical Co ranks #117 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 14.4%.
Is Xiangyu Medical Co's OCF Margin % too high?
Xiangyu Medical Co's current OCF Margin % of 11.15% is 64% below median its 10-year median of 30.60. Over the past 10 years, this metric has ranged from a low of 20.51 to a high of 43.67. The Medical Devices & Instruments industry median OCF Margin % is 6.65. Xiangyu Medical Co's value of 11.15% is 67.8% above this industry median. Based on the distribution chart, Xiangyu Medical Co ranks #117 out of 812 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Xiangyu Medical Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Xiangyu Medical Co's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Xiangyu Medical Co ranks #117 out of 812 companies for OCF Margin %. This places Xiangyu Medical Co in the top 14% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 6.65. Xiangyu Medical Co's value of 11.15% is 67.8% above this benchmark. Historically, Xiangyu Medical Co's own OCF Margin % has ranged from 20.51 to 43.67 over the past decade. While the company's 10-year median is 30.60 vs. the industry median of 6.65, Xiangyu Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.65, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xiangyu Medical Co's current OCF Margin % of 11.15% is 67.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Xiangyu Medical Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xiangyu Medical Co's current OCF Margin % is 11.15%, which is 64% below median its own 10-year median of 30.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiangyu Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Xiangyu Medical Co (SHSE:688626) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥46.28, compared to a current price of ¥39.76 — trading 14.1% below its estimated fair value. The current OCF Margin % is 11.15%, which is 64% below median its 10-year median of 30.60 and 67.8% above the Medical Devices & Instruments industry median of 6.65. Xiangyu Medical Co's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Xiangyu Medical Co (SHSE:688626), the current OCF Margin % is 11.15% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xiangyu Medical Co (SHSE:688626) Overvalued in 2026?
Based on GuruFocus' analysis, Xiangyu Medical Co stock appears to be undervalued.
The current stock price of ¥39.76 is trading 14.1% below its estimated GF Value™ of ¥46.28.
GuruFocus considers Xiangyu Medical Co to be Modestly Undervalued.
Key valuation signals for SHSE:688626:
OCF Margin %: 11.15% (64% below median its 10-year median of 30.60)
GF Value™: ¥46.28 vs. price of ¥39.76 (14.1% below fair value)
Industry Position: 67.8% above the Medical Devices & Instruments median (#117 of 812)
No single metric tells the full story. See the SHSE:688626 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xiangyu Medical Co Ltd is engaged in independent research and development, production and sales of intelligent rehabilitation equipment in the fields of pain rehabilitation, neurorehabilitation, orthopedics rehabilitation, postpartum rehabilitation, and medical care integration. The company's products are divided into three categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy.
91GF Score
Get the complete analysis for SHSE:688626
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688626 has been successfully added to your 
